New Psoriasis treatment available for patients suffering from acute and chronic Psoriasis
The landscape of psoriasis medications is increasing for a long time. Since 2017 new drugs approved by the FDA and in 2018, new drugs like tildrakizumab and Ixekizumab also made its debut in the sector. In the tandem of new medications, it’s impossible for a patient to determine which one is beneficial for them. The dangerous side effect of drugs and the growing awareness of herbal medicines might be a reason why many patients are moving towards herbal psoriasis treatment which offers remarkable results without any possible side effects. Abatacept: It is a fusion protein treatment administered subcutaneously on the patient which claims to disrupts the T-cell activation by binding to antigen presenting cells. In a 23-week phase 3 study at the American College of Rheumatology, the treatment shows 20 % improvement in the ACR20 metric in 39.4% of patients treated by Abatacept. However, dermatologists also say that the response of Psoriatic Skin is entirely diffe...
Comments
Post a Comment